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Left ventricular assist devices (LVAD) are mechanical pumps that have become a
standard treatment for end-stage heart failure. As patients with LVAD are living longer,
the number of noncardiac surgeries performed in these patients is rising. However,
these patients present a unique set of risk factors, some of which include acquired coagulopathies, anticoagulation status, and hemodynamic instability. Thus, performing
noncardiac surgeries in patients with an LVAD requires a precise and complex surgical
strategy with optimal communication among the surgical team. Therefore, knowledge
of best perioperative approaches for patients with LVAD is urgently needed. Here, we
present a detailed perioperative surgical approach in the case of a brain tumor resection for a 62-year-old patient with an LVAD whose course was complicated with a brain
hematoma. Critical details include key aspects of monitoring patient hemodynamic
stability and handling of anesthesia, patient positioning, and antiplatelet and anticoagulation drug therapy. This case highlights the importance for anesthesiologists to be
well informed about perioperative LVAD management, as well as common complications that they may encounter.

Introduction

Case Report

Approximately 550,000 cases of heart failure are diagnosed
annually, leading to over US$30 billion in healthcare expenditure in 2019.1 Left ventricular assist devices (LVAD), which
are surgically implanted mechanical pumps, have become
an integral aspect of treating end-stage heart failure. Studies
have shown that intracranial hemorrhage is a common complication in patients with LVAD, with a presentation rate
of 2.5 to 10%.2 We describe the unique management of a
brain tumor resection in a patient who had long-term LVAD
therapy.

A 62-year-old woman, (81.6 kg, 155 cm) presented with
3 weeks of dizziness, ataxia, nausea, headaches, dysmetria,
and upward gaze palsy. Brain imaging revealed a cerebellar
tumor (►Fig. 1). Her medical history included breast cancer
complicated with doxorubicin-induced cardiomyopathy for
which HeartMate 3 was placed. Home medications included
aspirin, furosemide, losartan, and warfarin. Her LVAD driveline site was clean and intact, and home LVAD parameters
included a flow of 3.5 L/min, pump speed of 5250 rpm, pump
power of 3.9 Watts, and pulsatility index (PI) of 8.
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Fig. 1 Metastatic tumor in cerebellum causing compression of fourth
ventricle and hydrocephalus. The patient had clinical symptoms of
dysmetria and upward gaze palsy. Image reproduced with patient
consent.

International normalized ratio (INR) at presentation
was 2.79. Aspirin and warfarin were withheld for INR goal
of less than 1.5. Heparin infusion as bridging anticoagulation therapy was started and paused 6 hours before surgery.
Immediately before surgery, INR was 1.26 and other laboratory values were unremarkable. A preoperative discussion
was held among the anesthesiologist, cardiologist, surgeon,
and LVAD nurse.
Standard anesthesia monitors were applied. Multiple
unsuccessful arterial cannulation attempts were made in the
right radial, brachial, and axillary arteries before a left axillary arterial line was placed under ultrasound guidance. An
18G external jugular vein cannula was placed after failure
of internal jugular vein visualization with ultrasound, and
inability to pass guidewire beyond 16 cm. Peripheral intravenous access included 20G right hand, 18G right foot, 18G right
forearm, and Mediport catheter terminating in superior vena
cava. Preoperative vital signs were 99% oxygen saturation
and mean arterial pressure (MAP) 95 mmHg. Intraoperative
oxygen saturation was maintained at 99% and MAP was
maintained between 80 and 85 mmHg. A mechanical circulatory support team, transesophageal echocardiogram (TEE),
and vasopressor and inotropic drugs were readily available.
Rapid sequence induction with GlideScope intubation was
performed. Anesthesia was maintained with isoflurane
1 minimum alveolar concentration and remifentanil infusion
at 0.08 to 0.1 mcg/kg/min. Ventilator settings were as follows: tidal volume 4 mL/kg, positive end-expiratory pressure
(PEEP) 5, and fraction of inspired oxygen 60%. Grounding
pad was placed in the lower extremity to avoid mechanical
interference. Bipolar cautery was used, and the surgeon was
advised to use cautery in short bursts. During transportation,
the LVAD was battery powered; in the operating room, it was
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connected to the power base unit, which was powered by an
electrical outlet.
The patient was positioned prone on gel rolls with her head
secured to the Mayfield frame. Special attention was paid
not to exert pressure onto the LVAD unit. Ephedrine 20 mg
was administered after positioning to correct a decreased
blood pressure. Crystalloids (2.2 L) were administered without transfusions, 1.1 L of urine was produced, blood loss was
200 mL, and LVAD parameters remained unchanged. After
surgery, she was extubated and transferred to the intensive
care unit in stable condition.
Subcutaneous heparin was started 48 hours after surgery
as prophylaxis, and heparin infusion was restarted for warfarin bridging, targeting an INR of 2 to 3. On postoperative day 5,
the patient developed worsening headache. Brain imaging
showed a cerebellar hematoma (►Fig. 2). Anticoagulation
was stopped, protamine sulfate was administered, and the
patient underwent uneventful emergency decompression
and hematoma evacuation. On postoperative day 24, she
attained therapeutic INR and was discharged.

Discussion
LVAD placement in patients with heart failure is projected to
grow as the number of older adults with heart disease increases
in the United States.3 Aging is correlated with increased cancer
risk4; therefore, anesthesiologists may increasingly encounter LVAD patients with malignancy, and these patients have
unique needs throughout the perioperative period.
Regarding all LVAD devices, the anesthesiologist should be
aware of the following specific LVAD parameters: (1) pump

Fig. 2 On postoperative day 5, the patient developed a constant
headache. Noncontrast head computed tomography showed a hematoma in the cerebellum with fourth ventricle compression and hydrocephalus. Image reproduced with patient consent.
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speed, (2) pump flow, (3) pump power, and (4) PI. Pump speed
is fixed and is initially programmed by the implanting physician to optimize left ventricular unloading and ejection. A
low fixed speed can cause increased risk for thrombosis, and
a high fixed speed may cause hemolysis and left ventricular
collapse through increased pump suction. Pump speeds for
HeartMate 3 devices range from 3000 to 9000 rpm, but the
clinically recommended range is 5000 to 6000 rpm. Power
refers to the amount of energy required for the impeller to
pump blood, which ranges from 4.5 to 6.5 W. A low power
may reflect low pump speed, an inflow cannula obstruction,
or decreased preload. A high power can be due to increased
preload, aortic insufficiency, or high pump speed. Pump flow
refers to the amount of blood that is provided to the systemic
circulation by the LVAD and ranges from 4 to 6 L/min. Pump
flow is correlated with power and is affected by fixed speed,
hematocrit, and the pressure gradient. Lastly, PI is a dimensionless index that averages the flow pulses (LVAD flow
waveform) over 15 seconds with clinically normal values
from 3.5 to 5.5. PI is increased with increased contractility
and preload, and reduced with decreased preload and afterload or obstruction.
For our patient, general anesthesia was used without any
issues. However, total intravenous anesthetic (TIVA) may have
been the optimal choice, since the patient had a brain tumor
with possible elevated intracranial pressure (ICP). Benefits of
TIVA include decreased ICP and lowered cerebral metabolic
rate oxygen consumption. The primary anesthesiologist felt
that the volatile anesthetic would be more controllable for
our patient. To optimize cerebral protection and decrease ICP,
we used lidocaine during induction and hyperventilation,
remifentanil infusion, mannitol 25 g intravenously, and head
elevation during intubation, extubation, and transfer.
Patients with LVAD are coagulopathic. To prevent pump
thrombosis, patients are given antiplatelet and anticoagulant
therapy (target INR of 2–3).5 Risk of stroke in patients with
LVAD is ~15%.6 High shear forces on blood flowing through the
LVAD can lead to worsened coagulopathy. For nonemergent
noncardiac surgery, anticoagulation is typically decreased
to the lower limits of manufacturers’ recommendations,
except for neurosurgical or ophthalmological procedures
that require full reversal.7 Patients presenting for emergent
surgery can be given fresh frozen plasma, prothrombin concentrate, and vitamin K to reverse warfarin, or protamine
sulfate for heparin. Intraoperative use of viscoelastic hemostatic assays can correct coagulopathy. However, clinicians
must be aware that LVAD patients have altered baseline coagulation; thus, trends rather than absolute values should be
followed.8 When postoperative bleeding risk is low, current
guidelines recommend restarting heparin for partial thromboplastin time of 60 to 80s until INR reaches 2 to 3 (level of
evidence 1B).5
In neurological operations, MAP should be kept between
70 and 80 mmHg to maintain cerebral perfusion in the setting
of ICP.9 For LVAD patients, MAP should be less than 85 mmHg,
as higher pressures can lead to pump stasis, flow reductions,
and increased cerebrovascular accidents. Cerebral oximetry
can be used to monitor cerebral tissue oxygenation. In our
Journal of Neuroanaesthesiology and Critical Care
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patient, remifentanil infusion and volatile anesthetic were
titrated for a MAP of 85 mm Hg without any long-term postoperative neurological sequelae.
Patients with LVAD are preload dependent on right ventricle (RV) function, so preoperatively assessing RV function
is important. Increased PEEP requirement during mechanical
ventilation can increase airway pressures, further exacerbating RV dysfunction. Signs of RV failure are elevated central
venous pressure, decreased urine output, increased capillary
refill time, increased lactate, and end-organ dysfunction.
Impaired RV contractility and leftward shift of the septum
may be seen on TEE. LVAD patients may also experience
device malfunction. Clinical signs are pump vibration, heart
failure symptoms, decreased power and flow, inability to
attain desired pump speed, and variable PI. TEE and mechanical circulatory support were available during our patient’s
treatment, but because the patient had stable hemodynamics and a functioning LVAD and to avoid surgery delay, preoperative TEE was not used.
Patient positioning can significantly affect hemodynamics
in patients with LVAD. Prone positioning can cause decreased
venous return leading to decreased preload and increased
afterload as a result of arterial compression. Additionally,
prone positioning might cause obstruction of the inflow
cannula and create a suctioning event, compromising left
ventricular end-diastolic filling and leading to systemic hypotension.10 Furthermore, prone positioning is associated with
increased pulmonary artery pressure, which may reduce forward blood flow in patients with LVAD. Treating hypotension
and assessing RV function with TEE are paramount should
hemodynamic instability occur. In these situations, TEE could
be placed after the patient is returned to supine position, or
carefully while in the prone position.

Conclusion
Patients with an LVAD who require noncardiac surgeries
pose a unique challenge to anesthesiologists. Our case highlights the importance of continually monitoring the LVAD
patient’s anticoagulation status and hemodynamic stability during surgery and being alert to possible postoperative
complications. Clear communication between anesthesiologists, cardiologists, surgeons, LVAD nurses, and ancillary staff
throughout the perioperative period is imperative.
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